PEDIATRICS
Expert Insight View All

Pimecrolimus as a preferred option for mild-to-moderate atopic dermatitis - An updated recommendation for south and east asia

Eczema, also known as atopic dermatitis (AD), is a chronic, relapsing, inflammatory skin disease characterized by intense itch, recurrent eczematous lesions, and a fluctuating course.1,2 Statistics showed that up to 20% of children are affected by AD worldwide, while 15% of secondary school children in Hong Kong are reported to have the problem.3,4 In addition, evidence has suggested the prevalence of AD in Asia is on the rise.2 Although AD can be controlled through various proven strategies, optimizing AD management is still a challenge since certain situations, such as steroid phobia and poor patient compliance, could lead to treatment failure.4 In these regards, an algorithm for the topical AD treatment was developed and published in 2020 for use by the primary care physicians, pediatricians, and dermatologists in South and East Asia.2 In the interviews with Omnihealth Practice, Dr. Luk, Chi-Kong David and Professor Hon, Kam-Lun Ellis, authors of the practical recommendations, discussed the difficulties in managing mild-to-moderate AD, and shared their views on improving treatment outcomes in these AD patients.

28 Oct 2021
thumb

Dr. Luk, Chi-Kong David

Specialist in Paediatrics
President,
The Hong Kong Paediatric and Adolescent Dermatology Society

thumb

Professor Hon, Kam-Lun Ellis

Professor of Practice,
Department of Paediatrics,
CUHK Medical Centre,
The Chinese University of Hong Kong

Conference Update View All
Infographics View All

Infant gut microbiota is associated with an increased risk of food allergies

24 Sep 2021
Features View All

Diagnosis and treatment of depression in pediatric and adult epilepsy

At the recent ILAE Europe Epilepsy Congress 2022, Professor Kette Valente delivered a presentation on recommendations for the diagnosis and treatment of depression for children with epilepsy, and Dr. Marco Mula presented on the possibility of taking antidepressants, as recommended by healthcare prov

16 Sep 2022
thumb

Professor Kette Valente

Full Professor of Child Neurology,
University of Sao Paulo Medical School

Director of the Clinical Neurophysiology Laboratory,
Clinics Hospital University of Sao Paolo

Chair of the Pediatric Commission of the International League Against Epilepsy (ILAE) 2021-2025
President of the Brazilian Chapter of the ILAE 2020-2022

thumb

Dr. Marco Mula

Atkinson Morley Regional Epilepsy Network,
St. George’s University Hospital,
St. George’s University of London,
United Kingdom